Pulmonary Hypertention. Pulmonary heart disease and diseases of pulmonary circulation
Conditions
Interventions
In this study 36 known case of pulmonary hypertension that had confirmed by Right Heart Catheterization will enter the study.Entering the study is based on patient's content and presence of Vitamin D
Treatment - Drugs
Sponsors
Islamic Azad University,Najafabad branch,Isfahan
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: History of Pulmonary Hypertension(Mean PAP more than 25mmHg by cardiac Catheterization);Presence of Vitamin D deficiency;Not using Vitamin D supplements before intervention;Patient's content Exclusion Criteria: Adverse reaction of medication during the intervention;Failing of patient to keep on the trial
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 6 Minute Walk Test. Timepoint: Before intervention and also after normalization of plasma level of Vitamin D. Method of measurement: This test measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6 minutes.;Pro-BNP. Timepoint: Before intervention and also after normalization of plasma level of Vitamin D. Method of measurement: Chimiluminescence.;Pulmonary Artery Pressure. Timepoint: Before intervention and also after normalization of plasma level of Vitamin D. Method of measurement: By Echocardiography and if need Right Heart catheterization. | — |
Secondary
| Measure | Time frame |
|---|---|
| Plasma level of Vitamin D. Timepoint: Before intervention and 3 months after treatment and if need 6 months later. Method of measurement: Chimiluminescence. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed